TechCrunch Startup News Spore.Bio raises $23M to apply machine learning to microbiology testing
Feb 24, 2025
A Paris-based startup is shaking up microbiology testing with a rapid method that promises results in mere minutes, transforming the food and beverage industry. With $23 million in Series A funding and a collaboration with the Pasteur Institute, they're on a mission to create efficient on-site testing machines. This innovation aims to prevent catastrophic consequences from contamination recalls, not just saving money but also preserving brand reputations.
AI Snips
Chapters
Transcript
Episode notes
Rapid Microbiology Testing
- Spore.bio aims to revolutionize microbiology testing in the food and beverage industry to prevent contamination incidents and PR crises.
- Their technology uses light and a deep learning algorithm to detect bacteria and pathogens, reducing testing time from days to minutes.
Spore.bio's Funding and Growth
- Spore.bio secured $23 million in Series A funding, shortly after an $8 million pre-seed round.
- This rapid fundraising reflects strong customer interest, with contracts covering 200 factories and a growing waitlist.
Revolutionizing Testing
- Traditional microbiology testing is slow and involves off-site lab work, causing delays in optimized manufacturing processes.
- Spore.bio's technology allows for on-site testing, drastically cutting down the waiting time for results.